Teva, Glenmark fined $255 million by DOJ to resolve price fixing charges
[ad_1] Boxes of tablets produced by Teva Pharmaceutical Industries. Chris Ratcliffe | Bloomberg | Getty Images Drugmaker Teva Pharmaceuticals agreed to pay $225 million in criminal fines to resolve charges related to price fixing three medications, including a generic cholesterol drug that it has agreed to divest, the U.S. Department of Justice announced Monday. Glenmark Pharmaceuticals…
